IL6 and Splenomegaly: While markers of acute infection (6 h IL-6 levels and chronic splenomegaly) and sepsis (acute hypothermia and long-term body weight loss) indicate little if any differences in sepsis severity between drug- and vehicle- treated sepsis survivors, we are unable completely rule out that SS-31 had no impact on initial sepsis severity without examining markers of organ damage.